ATRICURE

AtriCure, Inc.

@atricure

Mason, Ohio
http://www.atricure.com
Medical Equipment Manufacturing

Overview

About AtriCure, Inc.

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide.

Electrophysiologists, cardiothoracic and thoracic surgeons around the globe use AtriCure technologies for the treatment of Afib, reduction of Afib related complications and post-operative pain management. AtriCure’s Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib.

AtriCure’s AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients.

AtriCure’s cryoICE cryoSPHERE®+ and cryoSPHERE MAX™ probes are cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures.

For more information, visit AtriCure.com or follow us on X (formerly Twitter) @AtriCure.

Headquarters

Mason, Ohio

Website

http://www.atricure.com

Company Size

1,001-5,000 employees

Industry

Medical Equipment Manufacturing

Company Type

Public Company

Founded

2000

Specialties

Medical Devices, Manufacturing, Atrial Fibrillation, and Maze IV Training

Jobs

Posts